RecruitingPeripheral Arterial Disease
Advanta VXT and Flixene PMCF Registry
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of the registry is to evaluate the long-term safety and performance of Advanta VXT and Flixene vascular grafts for repair or replacement of peripheral arteries. This registry is also intended to provide further data on the clinical usefulness of the Advanta VXT and Flixene vascular grafts.
Sponsor: Atrium Medical Corporation
You may qualify if…
- ✓ Willing, and able to provide legally-effective written informed consent (as required by IRB/EC)
- ✓ Male and female patients that have undergone replacement or repair of the peripheral arteries using the Advanta VXT or Flixene vascular graft.
- ✓ Were at least 18 years of age at the time of the procedure
- ✓ Available records for data collection, with a minimum of 36 months of data/follow-up.
You may not qualify if…
- ✕ \- Active infection in the region of graft placement at the time of implantation of the Advanta VXT or Flixene vascular graft
Where it's recruiting
Massachusetts
Boston
Source: ClinicalTrials.gov · NCT07161583 · last updated 2026-03-13